Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn:
“Excellent perspective on the current challenges with adcs in the clinic.
- Therapeutic options in advanced breast cancer
- Challenges remain regarding optimal sequencing, tolerability, and global generalizability
- Next steps as we move forward include developing novel targets and payloads,and developing biomarkers.”
More posts featuring Shaheenah Dawood